
    
      Participants will have an acute e-cig exposure on 2 occasions 1) e-cigarette 2) sham e-cig
      (empty e-cig) control. Blood will be collected before and after E-cig use and analyzed for
      biomarkers of inflammation and oxidative stress.
    
  